Natco Pharma Ltd. Financials

15:59 May 21

Natco Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
875.60
+23.60 (+2.77%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Natco Pharma Ltd. Financials

Natco Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
875.60
+23.60 (+2.77%)
15:59 May 21
Quality
image/svg+xml

75/100
High Financial Strength

Valuation
image/svg+xml

64/100
Affordable Valuation

Technical

46/100
Technically Neutral

Strength

14

Weakness

7

Opportunity

0

Threats

1

23.71 %

ROE %

20.10 %

ROA %

104.13

EPS

326.99

BVPS

34.71 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
2052.1 1944.8 2707.1 3998.8 4276.8
Operating Expenses +
1445.9 1681.3 1771.5 2247.4 2131.6
Raw Material
559.5 577.7 651 673.9 651.2
Increase Decrease in Cost
-48.1 -16.8 -23.7 42.7 -68
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
414.9 444.8 486.7 525 577.6
Miscellaneous Expenses
892.8 792.6 1008.9 1308.6 970.8
Operating Profit
606.2 263.5 935.6 1751.4 2145.2
Other Income
103.6 99 104.6 128.1 330.2
Depreciation
116.9 142.6 163.8 186.8 192.4
Interest
13.3 17.7 14.5 19.2 19.9
Profit before tax and exceptio..
579.6 202.2 861.9 1673.5 2263.1
Exceptional Items
0 0 0 0 0
PBT
579.6 202.2 861.9 1673.5 2263.1
Provision for Taxation
137.2 32.2 146.6 285.2 399.4
Net Profit
442.4 170 715.3 1388.3 1863.7
NET Profit after MI
440.9 170 715.3 1388.3 1865.1
EPS
24.16 9.32 39.18 77.34 104.12
Operating Profit Margin (%)
29.54 13.55 34.56 43.8 50.16
Net Profit Margin (%)
21.49 8.74 26.42 34.72 43.61

Natco Pharma Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 49.60 49.60 49.60 49.70 49.70
FII 17.50 17.90 17.50 17.40 16.10
MF 1.80 1.90 2.40 2.70 4.10
Public 27.30 26.90 26.10 25.00 24.50
Others 0.00 0.00 0.00 0.00 0.00
Others 3.80 3.70 4.40 5.20 5.60
Shareholder Shares Holding %

Download Our App On: